Medikamentenreaktion mit Eosinophilie und systemischen Symptomen (DRESS)

• Literatur

• 1 Böhm Y, Proksch E, Schwarz T. et al. Drug hypersensitivity – diagnosis, genetics, and prevention. Dtsch Ärztebl Int 2018; 115: 501-512
• 2 Kardaun SH, Sideroff A, Valeyrie-Allanore L. et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms; does a DRESS syndrome really exist?. Br J Dermatol 2007; 156: 609-611
• 3 Pichler WJ. Immune pathomechanism and classification of drug hypersensitivity. Allergy 2019; 74: 1457-1471
• 4 Cho Y-T, Yang C-W, Chu Y-J. Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system. Int J Mol Sci 2017; 18: 1243
• 5 Kowtoniuk R, Pinninti M, Tyler W. et al. DRESS syndrome-associated acute necrotizing eosinophilic myocarditis with giant cells. BMJ 2018;
• 6 Mori F, Caffarelli C, Caimmi S. et al. Drug reaction with eosinophilia and systemic symptoms (DRESS) in children. Acta Biomed 2019; 3: 66-79
• 7 Morita C, Yanase T, Shiohara T. et al. Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with further development of type III polyglandular autoimmune syndrome. BMJ Case Rep 2018; 2018: bcr2018225528
• 8 Sharifzadeh S, Mohammadpour AH, Tavanaee A. et al. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review. Eur J Clin Pharmacol 2021; 77: 257-289
• 9 Jung HY, Park S, Shin B. et al. Prevalence and clinical features of drug reactions with eosinophilia and systemic syndrome caused by antituberculosis drugs: a retrospective cohort study. Allergy Asthma Immunol Res 2019; 11: 90-103